Skip to main content
Equibles
NKTX logo

NKTX · Nkarta, Inc. · Metrics

Track NKTX — free

Use NKTX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NKTX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.75 +0.00 (+0.00%)
Russell 2000 member Rebalance outlook locked
Market Cap
$125.34M
Shares
71.62M
Volume · Oct 19 1.44M Avg daily vol (3M) 653.97K

NKTX metrics

59 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$1.75
Market cap
$125.34M

Price action

20 metrics
Price change (1W)
-19.4%
Price change (30D)
-39.2%
Price change (3M)
-31.9%
Price change (6M)
-49.9%
Price change (YTD)
-5.4%
Price change (1Y)
-23.9%
Trailing year
Price change (5Y)
-89.8%
52-week high
$3.67
52-week low
$1.73
Change from 52-week high
-52.3%
Change from 52-week low
+1.2%
Annualized volatility
72.9%
Annualized volatility (3M)
61.8%
Beta
2.0
RSI (14D)
19.7
Price vs SMA 50
-31.9%
Price vs SMA 200
-31.3%
Avg volume (3M)
653,968
Relative volume
2.2
Average dollar volume
$1.61M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
71.62M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
0.5
reciprocal yield 192.2%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-91.0%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2025-11-13

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$132.25M
Net income (TTM)
−$117.32M
Trailing 12 months
Diluted EPS (TTM)
$-1.58
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$-1.78
EBITDA per diluted share (TTM)
$-1.65
Net income per diluted share (TTM)
$-1.58
Operating cash flow per diluted share (TTM)
$-1.25
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
$1.34
Stock compensation per diluted share (TTM)
$0.10
Book value per share
$4.39

Growth

11 metrics
Revenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+0.7%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-47.4%
Return on assets
-34.7%
Debt / equity
0.0
Current ratio
8.0
EBITDA (TTM)
−$122.65M
Free cash flow (TTM)
—
Quick ratio
8.0
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$182.76M
Latest balance sheet
Cash & equivalents
$24.96M
Total assets
$337.64M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$92.76M
Capital expenditures (TTM)
$1.15M
R&D (TTM)
$99.51M
SG&A (TTM)
—
Stock compensation (TTM)
$7.43M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
135
13F filer change QoQ
+9
Institutional ownership
83.0%

Short interest

3 metrics
Short interest
5.1%
Latest settlement · 5.9 days to cover
Days to cover
5.9d
Short-squeeze score
53 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1787400 CUSIP 65487U108 13F (30d) 12 filings 12 filers Visit website Investor relations